Drawing for BIOSINT

USPTO serial 98863619

BIOSINT

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
DIBLE, JONATHON I
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with BIOSINT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DEBORAH L. CORPUS

DEBORAH L. CORPUS Chrisman Gallo Tochtrop LLC629 Euclid Avenue, Suite 1101CLEVELAND, OH 44114United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical substances and biological preparations for the pharmaceutical, nutritional, and food industries, namely, carnitine and its salts and chemical derivates for use in the manufacture of pharmaceutical preparations, dietary supplements, and foodstuffs; Chemical substances, namely, carnitine and its salts and chemical derivates for the manufacture of pharmaceuticals, dietary supplements, and foodstuffs; All the aforementioned goods not for use in or with dental wax, dental and odontoiatric coating materials, materials for stopping teeth, and materials for zootechnicsACTIVE—
005Chemical and biological preparations for pharmaceutical use, namely, pharmaceutical preparations containing L-carnitine and its salts and chemical derivatives for the treatment and prevention of cardiovascular diseases, cancer diseases, kidney diseases, diseases and disorders of fat and glucose metabolism, primary and secondary L-carnitine deficiency, male infertility, mental and cognitive diseases, liver diseases, HIV and AIDS, tissue trauma and sepsis, malnutrition, aging, and bone loss; Chemical and biological preparations for medical use in the diagnosis of cardiovascular diseases, cancer diseases, kidney diseases, diseases and disorders of fat and glucose metabolism, primary and secondary L-carnitine deficiency, male infertility, mental and cognitive diseases, liver diseases, HIV and AIDS, tissue trauma and sepsis, malnutrition, aging, and bone loss; Dietetic substances and foodstuffs adapted for medical use containing L-carnitine and its salts and chemical derivatives; All the aforementioned goods not for use in or with dental wax, dental or odontoiatric coating materials, material for stopping teeth, and material for zootechnicsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 10, 2026EX2GSOU EXTENSION 2 GRANTED—
Sep 10, 2026EXT2SOU EXTENSION 2 FILED—
Sep 10, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 25, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 24, 2026EX1GSOU EXTENSION 1 GRANTED—
Jun 22, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 11, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2026EXT1SOU EXTENSION 1 FILED—
Sep 23, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 29, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 29, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 23, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 23, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 5, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 5, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 30, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2025DOCKASSIGNED TO EXAMINER—
May 10, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance